Answers are grounded in this paper and cite their sources.
BACKGROUND Varroa destructor control relies on a few synthetic acaricides, to which resistance is widespread. We assessed over 2 years how repeated field treatment with one acaricide changes mite susceptibility. Eighty honey bee colonies infested with one mite population of intermediate susceptibility were allocated by blocked randomization to coumaphos, amitraz, tau‐fluvalinate or oxalic acid (20 each), applied twice yearly after baseline sampling. Susceptibility was assessed before treatment (T0) and after two (T1) and four (T2) applications, using strip‐contact bioassays for coumaphos and amitraz and genotyping of the L925V mutation in the voltage‐gated sodium channel for pyrethroids. Data from 73 colonies (coumaphos, 16; amitraz, 20; tau‐fluvalinate, 19; oxalic acid, 18) were analyzed with linear mixed‐effects models. RESULTS In coumaphos‐treated colonies, coumaphos bioassay mortality fell from 42% (95% confidence interval (CI) 36–48) at T0 to 21% (15–27) at T1 and 19% (10–27) at T2, a decline of 25–36 percentage points larger than in the other three treatments ( P ≤ 0.001). In tau‐fluvalinate‐treated colonies, the proportion of mites carrying at least one susceptible L925 allele fell from 33% (24–43) at T0 to 8% (4–15) at T1 and 6% (1–23) at T2, a change differing from every other treatment ( P ≤ 0.018). In amitraz‐treated colonies, amitraz bioassay mortality decreased from 86% (82–90) to 74% (69–79) at T2, a change differing only from coumaphos‐treated colonies. CONCLUSION Four consecutive applications of coumaphos or tau‐fluvalinate within 2 years markedly reduced susceptibility to that compound, mostly after the first two applications. These results support acaricide rotation and regular susceptibility monitoring in V. destructor management.
No takes yet. Share an insight, caveat, or question.
Moreno‐Martí et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: